Market Overview

Benzinga's Top Downgrades

Share:
Related PRXL
Avondale Downgrades PAREXEL To Underperform, Cites MSA-Laden Backlog Concerns
Benzinga's Top Upgrades
Valentine 2016 Portfolio: Stocks To Love And Hate (Seeking Alpha)
Related MT
Benzinga's Top Upgrades
ArcelorMittal Falls Following Announcement Of Capital Raise, Sale Of Gestamp Stake
ArcelorMittal foresees South African steel protection (Seeking Alpha)

Analysts at Jefferies downgraded PAREXEL International (NASDAQ: PRXL) from “buy” to “hold.” PAREXEL's shares closed at $32.38 yesterday. PAREXEL's trailing-twelve-month ROA is 4.01%.

Analysts at Citigroup downgraded ArcelorMittal (NYSE: MT) from “buy” to “neutral.” ArcelorMittal's shares closed at $14.65 yesterday. ArcelorMittal's trailing-twelve-month profit margin is 0.69%.

Analysts at Goldman Sachs downgraded MeadWestvaco (NYSE: MWV) from “buy” to “neutral.” MeadWestvaco's shares closed at $31.20 yesterday. MeadWestvaco's PEG ratio is 2.16.

RBC Capital downgraded Endo Health Solutions (NASDAQ: ENDP) from “outperform” to “sector perform.” Endo Health's shares closed at $31.51 yesterday. Endo Health's trailing-twelve-month ROA is 5.13%.

Latest Ratings for PRXL

DateFirmActionFromTo
Jan 2016Avondale PartnersDowngradesMarket PerformMarket Underperform
Jan 2016Evercore ISI GroupUpgradesHoldBuy
Oct 2015SunTrust Robinson HumphreyMaintainsNeutral

View More Analyst Ratings for PRXL
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ENDP + MT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters